Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-01 | HAEMONETICS CORP | Galvin Roy
(President, Global Plasma & BC) |
F | Common Stock | D | 161 | $71.48 - $71.48 | $11,508 |
| 2024-09-17 | HAEMONETICS CORP | Miller Laurie A.
(SVP, Human Resources) |
F | Common Stock | D | 238 | $76.54 - $76.54 | $18,216 |
| 2024-07-26 | HAEMONETICS CORP | Strong Stewart W
(President, Global Hospital) |
S | Common Stock | D | 4312 | $91.15 - $91.15 | $393,038 |
| 2024-07-25 | HAEMONETICS CORP | Strong Stewart W
(President, Global Hospital) |
F | Common Stock | D | 2798 | $90.58 - $90.58 | $253,442 |
| 2024-07-24 | HAEMONETICS CORP | Strong Stewart W
(President, Global Hospital) |
A | Common Stock | A | 7110 | $0.00 - $0.00 | $0 |
| 2024-07-11 | HAEMONETICS CORP | Lingamneni Anila
(EVP, Chief Technology Officer) |
S | Common Stock | D | 2215 | $90.00 - $90.00 | $199,350 |
| 2024-05-28 | HAEMONETICS CORP | Lingamneni Anila
(EVP, Chief Technology Officer) |
F | Common Stock | D | 5279 | $95.73 - $95.73 | $505,358 |
| 2024-05-28 | HAEMONETICS CORP | Lingamneni Anila
(EVP, Chief Technology Officer) |
A | Common Stock | A | 14140 | $0.00 - $0.00 | $0 |
| 2024-05-28 | HAEMONETICS CORP | Llorens Josep
(EVP, Global Manufacturing) |
F | Common Stock | D | 4510 | $95.73 - $95.73 | $431,742 |
| 2024-05-28 | HAEMONETICS CORP | Llorens Josep
(EVP, Global Manufacturing) |
A | Common Stock | A | 14140 | $0.00 - $0.00 | $0 |
| 2024-05-29 | HAEMONETICS CORP | Basil Michelle L
(EVP and General Counsel) |
S | Common Stock | D | 12990 | $87.86 - $88.57 | $1,144,207 |
| 2024-05-28 | HAEMONETICS CORP | Basil Michelle L
(EVP and General Counsel) |
F | Common Stock | D | 11758 | $95.73 - $95.73 | $1,125,593 |
| 2024-05-28 | HAEMONETICS CORP | Basil Michelle L
(EVP and General Counsel) |
A | Common Stock | A | 24748 | $0.00 - $0.00 | $0 |
| 2024-05-28 | HAEMONETICS CORP | Miller Laurie A.
(SVP, Human Resources) |
F | Common Stock | D | 778 | $95.73 - $95.73 | $74,477 |
| 2024-05-28 | HAEMONETICS CORP | Miller Laurie A.
(SVP, Human Resources) |
A | Common Stock | A | 2650 | $0.00 - $0.00 | $0 |
| 2024-05-28 | HAEMONETICS CORP | Simon, Christopher
(President & CEO) |
F | Common Stock | D | 41736 | $95.73 - $95.73 | $3,995,387 |
| 2024-05-28 | HAEMONETICS CORP | Simon, Christopher
(President & CEO) |
A | Common Stock | A | 106062 | $0.00 - $0.00 | $0 |
| 2024-05-29 | HAEMONETICS CORP | Strong Stewart W
(President, Global Hospital) |
S | Common Stock | D | 8857 | $87.53 - $87.53 | $775,253 |
| 2024-05-28 | HAEMONETICS CORP | Strong Stewart W
(President, Global Hospital) |
F | Common Stock | D | 4399 | $95.73 - $95.73 | $421,116 |
| 2024-05-28 | HAEMONETICS CORP | Strong Stewart W
(President, Global Hospital) |
A | Common Stock | A | 13256 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |